Ypsomed Holding AG Logo

Ypsomed Holding AG

A developer and manufacturer of injection and infusion systems for self-administration.

YPSN | SW

Overview

Corporate Details

ISIN(s):
CH0019396990
LEI:
391200QLIOTTBNPNSI14
Country:
Switzerland
Address:
Brunnmattstrasse 6, 3400 Burgdorf

Description

Ypsomed is a leading developer and manufacturer of injection and infusion systems for the self-administration of liquid medications. The company partners with pharmaceutical and biotech companies to provide a comprehensive portfolio of self-injection devices, including pens, autoinjectors, and on-body devices. Ypsomed offers tailored self-care solutions and expert support services that cover every stage of product development. Its offerings are designed to integrate with digital health services and increasingly focus on sustainability, with innovations like autoinjectors designed for a circular economy. These systems aim to simplify therapy and improve the quality of life for patients with chronic conditions.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Ypsomed Holding AG filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Ypsomed Holding AG

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Ypsomed Holding AG via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2024-09-30 N/A Executive member Buy None 145,600.00 CHF
2024-09-26 N/A Executive member Sell None 129,352.00 CHF
2024-09-24 N/A Non-Executive member Buy None 42,776.00 CHF
2024-05-27 N/A Executive member Sell None 78,000.00 CHF
2024-05-22 N/A Executive member Sell None 154,000.00 CHF
2023-09-29 N/A Executive member Sell None 40,800.00 CHF
2022-06-23 N/A Non-Executive member Buy None 31,400.00 CHF
2022-06-23 N/A Executive member Buy None 11,760.00 CHF
2022-06-23 N/A Executive member Buy None 122.50 CHF
2022-06-14 N/A Non-Executive member Buy None 1,080,875.72 CHF

Peer Companies

3-D Matrix,Ltd. Logo
Develops peptide-based hydrogels to control bleeding in surgical procedures.
Japan
7777
aap Implantate AG Logo
Develops, manufactures, and markets implants for the treatment of bone fractures.
Germany
AAQ1
AcouSort AB Logo
Develops acoustofluidic solutions for automated biological sample processing.
Sweden
ACOU
Adagio Medical Holdings, Inc. Logo
Develops cryoablation technologies for treating cardiac arrhythmias like VT.
United States of America
ADGM
ADVANCED MEDICAL SOLUTIONS GROUP PLC Logo
Develops and manufactures innovative tissue-healing technologies for surgery and woundcare.
United Kingdom
AMS
AETHLON MEDICAL INC Logo
Develops immunotherapeutic devices to deplete exosomes and viruses from the blood.
United States of America
AEMD
Affluent Medical Logo
Develops minimally invasive implants for structural heart disease and urology.
France
AFME
AIOBIO Co., Ltd. Logo
Develops AI-driven diagnostic platforms and imaging devices for dental care.
South Korea
447690
Airway Medix S.A. Logo
Develops single-use medical devices for mechanically ventilated patients.
Poland
AWM
ALIGN TECHNOLOGY INC Logo
Designs and manufactures clear aligners, intraoral scanners, and digital services.
United States of America
ALGN

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.